Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kosaki, A.
Right arrow Articles by Kuzuya, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kosaki, A.
Right arrow Articles by Kuzuya, H.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 45, Issue 12 1744-1749, Copyright © 1996 by American Diabetes Association


ARTICLES

Reduced expression of the leptin gene (ob) by catecholamine through a G(S) protein-coupled pathway in 3T3-L1 adipocytes

A Kosaki, K Yamada and H Kuzuya
Clinical Research Unit, Diabetes Center, Kyoto National Hospital, Japan. atsukosa@jms06.jeton.or.jp.

Leptin, a recently identified hormone, is believed to reduce appetite and maintain body weight. The mRNA of leptin is expressed only in mature adipose cells. To clarify the regulation of leptin gene expression in adipocytes, 3T3-L1 adipocytes were treated for 16 h with various agents known to modulate lipid metabolism, and then the leptin mRNA was measured by the reverse transcription-polymerase chain reaction method. Interestingly, both norepinephrine and isoproterenol reduced the level of leptin mRNA to about 20% of that found in untreated control cells in a dose-dependent fashion. The maximum reduction occurred at 100 nmol/l of either norepinephrine or isoproterenol, and the half-maximal effect was observed at approximately 3 nmol/l norepinephrine and approximately 1 nmol/l isoproterenol. Propranolol reversed about 50% of the reduction by either norepinephrine or isoproterenol. In contrast, phentolamine did not inhibit the reduction by either norepinephrine or isoproterenol. Moreover, both cholera toxin and dibutyryl cAMP decreased the level of leptin mRNA to about 10% of that in control cells in a dose-dependent fashion. The maximum effect was elicited at 100 ng/ml cholera toxin and 100 micromol/l dibutyryl cAMP. The concentration producing the half-maximal effect was approximately 1 ng/ml cholera toxin and approximately 50 micromol/l dibutyryl cAMP. Dibutyryl cGMP, however, did not affect leptin gene expression. These results suggest that a signaling pathway that results in the activation of protein kinase A regulates leptin gene expression in 3T3-L1 adipocytes.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
M.-J. Lee and S. K. Fried
Multilevel regulation of leptin storage, turnover, and secretion by feeding and insulin in rat adipose tissue
J. Lipid Res., September 1, 2006; 47(9): 1984 - 1993.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. Simler, A. Grosfeld, A. Peinnequin, M. Guerre-Millo, and A.-X. Bigard
Leptin receptor-deficient obese Zucker rats reduce their food intake in response to hypobaric hypoxia
Am J Physiol Endocrinol Metab, March 1, 2006; 290(3): E591 - E597.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. I. C. Alonso-Vale, S. Andreotti, S. B. Peres, G. F. Anhe, C. das Neves Borges-Silva, J. C. Neto, and F. B. Lima
Melatonin enhances leptin expression by rat adipocytes in the presence of insulin
Am J Physiol Endocrinol Metab, April 1, 2005; 288(4): E805 - E812.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
Y. Ning, M.A. Williams, C.L. Butler, M. Muy-Rivera, I.O. Frederick, and T.K. Sorensen
Maternal recreational physical activity is associated with plasma leptin concentrations in early pregnancy
Hum. Reprod., February 1, 2005; 20(2): 382 - 389.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. W. Franks, I. S. Farooqi, J.'a. Luan, M.-Y. Wong, I. Halsall, S. O'Rahilly, and N. J. Wareham
Does Physical Activity Energy Expenditure Explain the Between-Individual Variation in Plasma Leptin Concentrations after Adjusting for Differences in Body Composition?
J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3258 - 3263.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Charmandari, M. Weise, S. R. Bornstein, G. Eisenhofer, M. F. Keil, G. P. Chrousos, and D. P. Merke
Children with Classic Congenital Adrenal Hyperplasia Have Elevated Serum Leptin Concentrations and Insulin Resistance: Potential Clinical Implications
J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2114 - 2120.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
D. Simon, M.-A. Charles, N. Lahlou, K. Nahoul, J.-M. Oppert, M. Gouault-Heilmann, N. Lemort, N. Thibult, E. Joubert, B. Balkau, et al.
Androgen Therapy Improves Insulin Sensitivity and Decreases Leptin Level in Healthy Adult Men With Low Plasma Total Testosterone: A 3-month randomized placebo-controlled trial
Diabetes Care, December 1, 2001; 24(12): 2149 - 2151.
[Full Text] [PDF]


Home page
FASEB J.Home page
M. BUYSE, S. VIENGCHAREUN, A. BADO, and M. LOMBES
Insulin and glucocorticoids differentially regulate leptin transcription and secretion in brown adipocytes
FASEB J, June 1, 2001; 15(8): 1357 - 1366.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
Y. ZHANG, C. HUFNAGEL, S. EIDEN, K.-Y. GUO, P. A. DIAZ, R. L. LEIBEL, and I. SCHMIDT
Mechanisms for LEPR-mediated regulation of leptin expression in brown and white adipocytes in rat pups
Physiol Genomics, January 19, 2001; 4(3): 189 - 199.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. M. Rice, J. N. Fain, and S. A. Rivkees
A1 Adenosine Receptor Activation Increases Adipocyte Leptin Secretion
Endocrinology, April 1, 2000; 141(4): 1442 - 1445.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Choi, R. Sparks, M. Clay, and M. F. Dallman
Rats with Hypothalamic Obesity Are Insensitive to Central Leptin Injections
Endocrinology, October 1, 1999; 140(10): 4426 - 4433.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Carulli, S. Ferrari, M. Bertolini, E. Tagliafico, and G. Del Rio
Regulation of ob Gene Expression: Evidence for Epinephrine-Induced Suppression in Human Obesity
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3309 - 3312.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
M. F. Dallman, S. F. Akana, S. Bhatnagar, M. E. Bell, S. Choi, A. Chu, C. Horsley, N. Levin, O. Meijer, L. R. Soriano, et al.
Starvation: Early Signals, Sensors, and Sequelae
Endocrinology, September 1, 1999; 140(9): 4015 - 4023.
[Abstract] [Full Text]


Home page
HeartHome page
D R Murdoch, E Rooney, H J Dargie, D Shapiro, J J Morton, and J J V McMurray
Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure
Heart, September 1, 1999; 82(3): 352 - 356.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-Y. Wang, Y. Lee, and R. H. Unger
Novel Form of Lipolysis Induced by Leptin
J. Biol. Chem., June 18, 1999; 274(25): 17541 - 17544.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
E. Jequier and L. Tappy
Regulation of Body Weight in Humans
Physiol Rev, April 1, 1999; 79(2): 451 - 480.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
P. Laharrague, D. Larrouy, A.-m. Fontanilles, N. Truel, A. Campfield, R. Tenenbaum, J. Galitzky, J. X. Corberand, L. Pénicaud, and L. Casteilla
High expression of leptin by human bone marrow adipocytes in primary culture
FASEB J, June 1, 1998; 12(9): 747 - 752.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Sakane, T. Yoshida, T. Mizutani, and Y. Nakagaw
Serum Leptin Levels in a Patient with Pheochromocytomah
J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1400 - 1400.
[Full Text]


Home page
J. Biol. Chem.Home page
A. Kosaki, K. Yamada, J. Suga, A. Otaka, and H. Kuzuya
14-3-3beta Protein Associates with Insulin Receptor Substrate 1 and Decreases Insulin-stimulated Phosphatidylinositol 3'-Kinase Activity in 3T3L1 Adipocytes
J. Biol. Chem., January 9, 1998; 273(2): 940 - 944.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
W. T. Donahoo, D. R. Jensen, T. J. Yost, and R. H. Eckel
Isoproterenol and Somatostatin Decrease Plasma Leptin in Humans: A Novel Mechanism Regulating Leptin Secretion
J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4139 - 4143.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Masuzaki, Y. Ogawa, K. Hosoda, T. Miyawaki, I. Hanaoka, J. Hiraoka, A. Yasuno, H. Nishimura, Y. Yoshimasa, S. Nishi, et al.
Glucocorticoid Regulation of Leptin Synthesis and Secretion in Humans: Elevated Plasma Leptin Levels in Cushing's Syndrome
J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2542 - 2547.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1996 by the American Diabetes Association.